Technology | Population Health | April 03, 2015

PatientPoint Population Health Management Application Receives Meaningful Use Certification

Software provides automated outreach from physicians to patients

April 3, 2015 — PatientPoint announced that PatientPoint Outreach 3.2 is now certified for Meaningful Use in an ambulatory setting. The software is also compliant with the Office of the National Coordinator (ONC) 2014 Edition criteria for certified electronic health record technology (CEHRT).

The ONC 2014 Edition criteria supports both Stage 1 and Stage 2 Meaningful Use measures that are required to qualify eligible providers for funding under the American Recovery and Reinvestment Act (ARRA).

PatientPoint Outreach 3.2 provides trusted and secure communications on behalf of the physician, and is highly customizable to a provider’s goals. By helping to manage patient adherence and follow-up, it can play a key role in improving clinical outcomes throughout the care continuum.

Driven by a population health analytics engine, the software provides automated outreach by email, text and interactive voice response (IVR), depending on the patient's stated preference. Eligible providers can submit against the Stage 1 and Stage 2 criteria for patient list creation and patient reminders.

PatientPoint Outreach 3.2 was certified by the Certification Commission for Health Information Technology (CCHIT) in accordance with the applicable Eligible Provider certification criteria adopted by the Secretary of Health and Human Services. PatientPoint certification (#IG-3251-15-0016) meets the following criteria:

  • 170.314(a)(14) Patient List Creation and Reminders
  • 170.314(g)(2) Automated Measures
  • 170.314(g)(4) Quality Management System

 

The application was certified by Infogard, an Accredited Testing Laboratory (NVLAP Lab Code: 100432-0) and ONC-Authorized Certification Body to test and certify Electronic Health Record (EHR) products for the ONC HIT Certification Program. InfoGard provides information technology services for organizations within the healthcare, financial, and federally mandated markets.

For more information: www.patientpoint.com


Related Content

News | Heart Failure

Oct. 22, 2025 – Ventric Health, a medtech innovator enabling early detection of heart failure (HF) in a primary care ...

Home October 28, 2025
Home
News | Heart Failure

Oct. 16, 2025 — Imbria Pharmaceuticals, has announced a partnership with the Hypertrophic Cardiomyopathy Association ...

Home October 16, 2025
Home
News | Heart Failure

Sept. 24, 2025 — The Family Heart Foundation, a leading research and advocacy organization, has announced the online ...

Home September 24, 2025
Home
News | Heart Failure

Sept. 22, 2025 — The latest findings on heart failure (HF) published by the Heart Failure Society of America (HFSA) ...

Home September 22, 2025
Home
News | Heart Failure

Sept. 11, 2025 — Newswise — A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women ...

Home September 15, 2025
Home
News | Heart Failure

Aug. 14, 2025 — Analytics For Life, in collaboration with its U.S. commercial partner CorVista Health, announced they ...

Home August 15, 2025
Home
News | Heart Failure

Aug. 6, 2025 — Ventric Health, a medtech company enabling early detection of heart failure (HF) in a primary care ...

Home August 06, 2025
Home
News | Heart Failure

July 14, 2025 — Bayer has announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA (finerenone) to ...

Home July 14, 2025
Home
News | Heart Failure

June 23, 2025 — iRhythm Technologies, Inc. announced the results from two large-scale real-world studies presented at ...

Home June 25, 2025
Home
News | Heart Failure

June 3, 2025 — Bayer announced it will present multiple new analyses of the Kerendia (finerenone) clinical trial program ...

Home June 04, 2025
Home
Subscribe Now